Lung cancer - Second Annual Winter Conference.
Edelman
Martin J
MJ
University of Maryland, Division of Hematology/Oncology, Greenebaum Cancer Center, Baltimore, 21201, USA. medelman@umm.edu
D002282:Adenocarcinoma, Bronchiolo-Alveolar / Q000188:drug therapy; D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry / Q000627:therapeutic use*; D001897:Boronic Acids / Q000737:chemistry / Q000627:therapeutic use; D000069286:Bortezomib; D016190:Carboplatin / Q000737:chemistry / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy; D018288:Carcinoma, Small Cell / Q000188:drug therapy; D017024:Chemotherapy, Adjuvant / Q000639:trends; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D000069347:Erlotinib Hydrochloride; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D015394:Molecular Structure; D017239:Paclitaxel / Q000737:chemistry / Q000627:therapeutic use; D011719:Pyrazines / Q000737:chemistry / Q000627:therapeutic use; D011799:Quinazolines / Q000737:chemistry / Q000627:therapeutic use
D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D011799:Quinazolines; D000069286:Bortezomib; D016190:Carboplatin; D000069347:Erlotinib Hydrochloride; D066246:ErbB Receptors; D017239:Paclitaxel